Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10559214rdf:typepubmed:Citationlld:pubmed
pubmed-article:10559214lifeskim:mentionsumls-concept:C0318041lld:lifeskim
pubmed-article:10559214lifeskim:mentionsumls-concept:C0016223lld:lifeskim
pubmed-article:10559214lifeskim:mentionsumls-concept:C1427984lld:lifeskim
pubmed-article:10559214lifeskim:mentionsumls-concept:C0007382lld:lifeskim
pubmed-article:10559214lifeskim:mentionsumls-concept:C0441712lld:lifeskim
pubmed-article:10559214lifeskim:mentionsumls-concept:C1295213lld:lifeskim
pubmed-article:10559214pubmed:issue47lld:pubmed
pubmed-article:10559214pubmed:dateCreated1999-12-14lld:pubmed
pubmed-article:10559214pubmed:abstractText2-Hydroxybiphenyl 3-monooxygenase (EC 1.14.13.44) from Pseudomonas azelaica HBP1 is an FAD-dependent aromatic hydroxylase that catalyzes the conversion of 2-hydroxybiphenyl to 2, 3-dihydroxybiphenyl in the presence of NADH and oxygen. The catalytic mechanism of this three-substrate reaction was investigated at 7 degrees C by stopped-flow absorption spectroscopy. Various individual steps associated with catalysis were readily observed at pH 7.5, the optimum pH for enzyme turnover. Anaerobic reduction of the free enzyme by NADH is a biphasic process, most likely reflecting the presence of two distinct enzyme forms. Binding of 2-hydroxybiphenyl stimulated the rate of enzyme reduction by NADH by 2 orders of magnitude. The anaerobic reduction of the enzyme-substrate complex involved the formation of a transient charge-transfer complex between the reduced flavin and NAD(+). A similar transient intermediate was formed when the enzyme was complexed with the substrate analog 2-sec-butylphenol or with the non-substrate effector 2,3-dihydroxybiphenyl. Excess NAD(+) strongly stabilized the charge-transfer complexes but did not give rise to the appearance of any intermediate during the reduction of uncomplexed enzyme. Free reduced 2-hydroxybiphenyl 3-monooxygenase reacted rapidly with oxygen to form oxidized enzyme with no appearance of intermediates during this reaction. In the presence of 2-hydroxybiphenyl, two consecutive spectral intermediates were observed which were assigned to the flavin C(4a)-hydroperoxide and the flavin C(4a)-hydroxide, respectively. No oxygenated flavin intermediates were observed when the enzyme was in complex with 2, 3-dihydroxybiphenyl. Monovalent anions retarded the dehydration of the flavin C(4a)-hydroxide without stabilization of additional intermediates. The kinetic data for 2-hydroxybiphenyl 3-monooxygenase are consistent with a ternary complex mechanism in which the aromatic substrate has strict control in both the reductive and oxidative half-reaction in a way that reactions leading to substrate hydroxylation are favored over those leading to the futile formation of hydrogen peroxide. NAD(+) release from the reduced enzyme-substrate complex is the slowest step in catalysis.lld:pubmed
pubmed-article:10559214pubmed:languageenglld:pubmed
pubmed-article:10559214pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10559214pubmed:citationSubsetIMlld:pubmed
pubmed-article:10559214pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10559214pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10559214pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10559214pubmed:statusMEDLINElld:pubmed
pubmed-article:10559214pubmed:monthNovlld:pubmed
pubmed-article:10559214pubmed:issn0021-9258lld:pubmed
pubmed-article:10559214pubmed:authorpubmed-author:van BerkelW...lld:pubmed
pubmed-article:10559214pubmed:authorpubmed-author:KohlerH PHPlld:pubmed
pubmed-article:10559214pubmed:authorpubmed-author:SuskeW AWAlld:pubmed
pubmed-article:10559214pubmed:issnTypePrintlld:pubmed
pubmed-article:10559214pubmed:day19lld:pubmed
pubmed-article:10559214pubmed:volume274lld:pubmed
pubmed-article:10559214pubmed:ownerNLMlld:pubmed
pubmed-article:10559214pubmed:authorsCompleteYlld:pubmed
pubmed-article:10559214pubmed:pagination33355-65lld:pubmed
pubmed-article:10559214pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:10559214pubmed:meshHeadingpubmed-meshheading:10559214...lld:pubmed
pubmed-article:10559214pubmed:meshHeadingpubmed-meshheading:10559214...lld:pubmed
pubmed-article:10559214pubmed:meshHeadingpubmed-meshheading:10559214...lld:pubmed
pubmed-article:10559214pubmed:meshHeadingpubmed-meshheading:10559214...lld:pubmed
pubmed-article:10559214pubmed:meshHeadingpubmed-meshheading:10559214...lld:pubmed
pubmed-article:10559214pubmed:meshHeadingpubmed-meshheading:10559214...lld:pubmed
pubmed-article:10559214pubmed:meshHeadingpubmed-meshheading:10559214...lld:pubmed
pubmed-article:10559214pubmed:year1999lld:pubmed
pubmed-article:10559214pubmed:articleTitleCatalytic mechanism of 2-hydroxybiphenyl 3-monooxygenase, a flavoprotein from Pseudomonas azelaica HBP1.lld:pubmed
pubmed-article:10559214pubmed:affiliationDepartment of Microbiology, Swiss Federal Institute of Environmental Sciences and Technology (EAWAG), CH-8600 Dübendorf, The Netherlands.lld:pubmed
pubmed-article:10559214pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10559214pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10559214lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10559214lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10559214lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10559214lld:pubmed